Y-mabs therapeutics sued for securities law violations; investors should contact block & leviton for more information

Boston, massachusetts--(newsfile corp. - january 20, 2023) - block & leviton announces that a class action lawsuit has been filed against y-mabs therapeutics, inc. (nasdaq: ymab) for securities law violations. investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those losses. for more details, visit https://www.blockleviton.com/cases/ymab.what is this all about?on october 26, 2022, briefing documents posted to the u.s.
YMAB Ratings Summary
YMAB Quant Ranking